Craig B Reeder
Overview
Explore the profile of Craig B Reeder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
2058
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chohan K, Paludo J, Dasari S, Mondello P, Novak J, Abeykoon J, et al.
Blood
. 2024 Jul;
144(12):1284-1289.
PMID: 38968152
Currently, the role of DNA methylation in the immunoglobulin M (IgM) monoclonal gammopathy disease spectrum remains poorly understood. In the present study, a multiomics prospective analysis was conducted integrating DNA...
2.
Chohan K, Paludo J, Dasari S, Mondello P, Novak J, Abeykoon J, et al.
Haematologica
. 2023 Dec;
109(5):1570-1575.
PMID: 38058213
No abstract available.
3.
Shahin A, Greene A, Reeder C, Costello C, Pittelkow M, DiCaudo D
JAAD Case Rep
. 2023 Nov;
41:110-112.
PMID: 37920700
No abstract available.
4.
Alhaj Moustafa M, Parrondo R, Abdulazeez M, Roy V, Sher T, Alegria V, et al.
Anticancer Drugs
. 2023 Apr;
35(1):63-69.
PMID: 37067996
Daratumumab is an anti-CD38 mAb, used frequently in combination with lenalidomide and pomalidomide. No studies compared daratumumab plus lenalidomide and dexamethasone (DRd) to daratumumab plus pomalidomide and dexamethasone (DPd) in...
5.
Wiedmeier-Nutor J, Iqbal M, Rosenthal A, Bezerra E, Garcia-Robledo J, Bansal R, et al.
Clin Lymphoma Myeloma Leuk
. 2023 Apr;
23(6):456-462.
PMID: 37003846
COVID-19 adversely affects individuals with cancer. Several studies have found that seroconversion rates among patients with hematologic malignancies are suboptimal when compared to patients without cancer. Patients with non-Hodgkin lymphoma...
6.
Chohan K, Paludo J, Vallumsetla N, Larson D, King R, He R, et al.
Am J Hematol
. 2023 Jan;
98(3):432-439.
PMID: 36588384
Waldenström macroglobulinemia (WM) is a rare, indolent lymphoma, that predominately affects the elderly. We report the outcomes of young WM patients, evaluated over five decades, compared to their older counterparts,...
7.
Mondello P, Paludo J, Novak J, Wenzl K, Yang Z, Jalali S, et al.
Clin Cancer Res
. 2022 Dec;
29(5):957-970.
PMID: 36534518
Purpose: IgM monoclonal gammopathy of undetermined significance (MGUS) and Waldenström macroglobulinemia (WM) represent a disease spectrum with highly varied therapeutic management, ranging from observation to chemoimmunotherapy. The current classification relies...
8.
Chohan K, Abeykoon J, Ansell S, Gertz M, Kapoor P, Paulus A, et al.
Leuk Lymphoma
. 2022 Jul;
63(12):2879-2888.
PMID: 35876190
Considerable healthcare resource utilization and financial burden have been associated with the treatment of WM; however, the impact of health insurance status on outcomes has not been previously reported. We...
9.
Muchtar E, Dispenzieri A, Gertz M, Kumar S, Buadi F, Leung N, et al.
Mayo Clin Proc
. 2021 Jun;
96(6):1546-1577.
PMID: 34088417
Immunoglobulin light chain (AL) amyloidosis is a clonal plasma cell disorder leading to progressive and life-threatening organ failure. The heart and the kidneys are the most commonly involved organs, but...
10.
Gunaratne M, Sahakian A, Abeykoon J, Ansell S, Gertz M, Kapoor P, et al.
Leuk Lymphoma
. 2020 Oct;
62(2):308-315.
PMID: 33054437
Waldenstrom macroglobulinemia (WM) has an annual incidence of 3-3.2 cases per million-person/year. National Cancer Data Base was used to identify newly diagnosed WM cases requiring initiation of therapy and their...